Webinar: How late 2017 has changed medtech


This webinar was presented live on Wednesday, October 11, 2017. Click below to watch on demand.




When it comes to news out of the U.S. government: one word could sum up what it means for the medical device industry: “uncertainty.”

It was true at the start of 2017. And it is even truer today.

The effort to repeal and replace the Affordable Care Act is dead for now, a permanent repeal of the medical device tax is unclear, and FDA fee hikes taking effect Oct. 1 could affect innovation in surprising ways. Meanwhile, major M&A deals continue, with Stryker making a $701 million fluorescence imaging technology play with its acquisition of Novadaq.


Featured Speaker:


Chris Newmarker
Managing Editor
Medical Design & Outsourcing






How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.

Register now with the code "TAVR" and save 15% today.

Speak Your Mind